May 5, 2009in Infringement, Patents, Pharmaceutical Drugs0by Editor744 United States Doctrine of Inequitable Conduct Under Scrutiny Again The controversial doctrine of inequitable conduct has once again garnered much attention in the patent law community due to the recent denial of certiorari by the US Supreme Court in Aventis Pharma v.…
